SOPHARMA AD: Notification from Rositsa Doneva under Art. 19 of Regulation (EU) № 596/2014 of the European Parliament and of the Council of April 16, 2014 from 10 October 2023.

2023-10-12 15:25

publikacja
2023-10-12 15:25

Spis treści:

3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Spis załączników:
RDoneva_Sopharma_EN_10102023.pdf (REPORT)

POLISH FINANCIAL SUPERVISION AUTHORITY
		UNI - EN REPORT No		187	/	2023
Date of issue:	2023-10-12
Short name of the issuer
SOPHARMA AD
Subject
Notification from Rositsa Doneva under Art. 19 of Regulation (EU) № 596/2014 of the European Parliament and of the Council of April 16, 2014 from 10 October 2023.
Official market - legal basis
art. 56. 1. 2 of Act on Public Offering.
Unofficial market - legal basis
Contents of the report:
Notification from Rositsa Doneva under Art. 19 of Regulation (EU) № 596/2014 of the European Parliament and of the Council of April 16, 2014 from 10 October 2023.
Annexes
File			Description
RDoneva_Sopharma_EN_10102023.pdfRDoneva_Sopharma_EN_10102023.pdf			Notification from Rositsa Doneva under Art. 19 of Regulation (EU) № 596/2014 of the European Parliament and of the Council of April 16, 2014 from 10 October 2023.

SOPHARMA AD

(fullname of the issuer)

SOPHARMA AD

Farmaceutyczny (far)

(short name of the issuer)

(sector according to clasification
of the WSE in Warsow)

1220

Sofia

(post code)

(city)

IlienskoShosse

(street)

(number)

+359 2 813 42 00

+359 2 936 02 86

(phone number)

(fax)

(e-mail)

(web site)

(NIP)

(REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Date	Name	Position / Function	Signature
2023-10-12	Ognian Donev	Executive director

Ważne linki